Effect of Peer-led Educational Intervention on Treatment Outcomes Among Adults With Drug-susceptible Pulmonary Tuberculosis in South Omo and Ari Zone, Southern Ethiopia
DS-PTB
1 other identifier
interventional
250
1 country
1
Brief Summary
The study might come up with valuable findings to address poor treatment outcome, poor quality of life, disability score and depressive symptoms. The findings may also be decreased health professional workload. The findings would be supportive evidences for policy makers, program managers, to clinician as well as the patients themselves and for other researchers. The study may help to promote and maintain good treatment outcome for the patients in the study area as well as the country. The findings will also be used for teaching \& learning purposes in educational \& training programs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 28, 2026
CompletedFirst Posted
Study publicly available on registry
February 4, 2026
CompletedStudy Start
First participant enrolled
February 19, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 12, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 22, 2026
CompletedJuly 6, 2026
February 1, 2026
5 months
January 28, 2026
July 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
treatment success rate
as defined by 7th edition of Ethiopian guidelines for clinical and programmatic management of TB, TB/HIV, DR-TB and Leprosy and by WHO. Data on the patients' status on the primary outcome variable will be extracted from TB register logbook.
the primary outcome will be measured at the end of 6 months i.e after July 24/2026
Study Arms (1)
Peer-Led Educational Intervention plus Standard TB Treatment
ACTIVE COMPARATORParticipants in this arm received a structured peer-led educational intervention in addition to standard anti-tuberculosis therapy for drug-susceptible pulmonary tuberculosis. The intervention consisted of education and support sessions delivered by trained peer educators who were previously treated and successfully cured of drug-susceptible pulmonary TB. The sessions focused on improving treatment adherence, enhancing knowledge about tuberculosis and its transmission, managing medication side effects, reducing stigma, and promoting healthy behaviors during treatment. The peer-led sessions were conducted \[weekly/biweekly/monthly - specify\] over the course of the standard TB treatment period (typically 6 months), using interactive methods such as group discussions, experience sharing, question-and-answer sessions, and motivational support. Educational materials were provided to reinforce key messages
Interventions
The Intervention is a structured, evidence-based program designed to promote positive and sustained behavioral changes among participants through education, counseling, and supportive follow-up
Eligibility Criteria
You may qualify if:
- Adults with new drug-susceptible pulmonary TB who will be diagnosed in bacteriological diagnostic methods
- not participating in similar study,
- mentally capable to provide consent,
- physically capable of following the intervention.
You may not qualify if:
- Seriously ill patients at the time of screening or enrollment
- Tuberculosis patients with a known plan to be transferred out of the study sites
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jinka University
Jinka, Southern Ethiopia, Ethiopia
Related Publications (1)
Authors (full names or at least last name + initials, in order) Article title Journal name Publication date (year, and month if available) Volume number Page numbers
RESULT
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2026
First Posted
February 4, 2026
Study Start
February 19, 2026
Primary Completion
July 12, 2026
Study Completion
July 22, 2026
Last Updated
July 6, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- February 10/2026-July 24/2026
- Access Criteria
- up on the request the correspondence author
The following individual participant data (IPD) will be shared: demographic information (age, sex, ethnicity), clinical measurements (blood pressure, weight, laboratory test results), questionnaire responses (PHQ-9 scores for depression, quality of life scores), and study outcomes (treatment response, adverse events). All data will be de-identified to protect participant privacy